| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/16/2009 | US7547440 Derived from Japanese cypress pollen allergen; stimulates lymphocytes; reduce symptoms of pollinosis; immunotherapy and diagnosing spring tree pollinosis (Hay fever) |
| 06/16/2009 | US7547439 Elicit immune response from human lymphocytes when complexed with a major histocompatibility complex molecule type HLA-A2; polypeptide |
| 06/16/2009 | US7547438 CD40-binding activating antibodies |
| 06/16/2009 | US7547437 Kidney or liver fibrosis; using antagonist against the mitogenic vascular endothelial growth factors (zvegf3), such as a monoclonal antibody against zvegf3, receptor binding variants, or antisense agents; antagonist of zvegf3 inhibits cell proliferation; humanized, single-chain antibody |
| 06/16/2009 | US7547436 Receptor specific transepithelial transport of therapeutics |
| 06/16/2009 | US7547435 Treating or preventing an eye disorder using a composition comprising a truncated plasmin protein comprising a catalytic domain of plasmin (TPCD) |
| 06/16/2009 | CA2476934C Stabilized tnfr-fc composition comprising arginine |
| 06/16/2009 | CA2405136C Treatment of tumors with rar alpha selective retinoid compounds in combination with other anti-tumor agents |
| 06/16/2009 | CA2399910C Mammalian secreted group iii phospholipase a2 |
| 06/16/2009 | CA2330500C Pharmaceutical compositions capable of being gelled |
| 06/16/2009 | CA2326327C Recombinant adeno-associated virus vector encoding alpha-1-antitrypsin serum protein |
| 06/16/2009 | CA2319437C Methods and reagents for decreasing allergic reactions |
| 06/16/2009 | CA2282727C Cell surface molecule mediating cell adhesion and signal transmission |
| 06/16/2009 | CA2266439C Neutrokine .alpha. |
| 06/16/2009 | CA2243201C Process for producing sustained-release preparation |
| 06/16/2009 | CA2192786C Cyclopeptolide inhibitors of adhesion molecules |
| 06/16/2009 | CA2158322C Immunoconjugate comprising an anti-egf receptor antibody and interleukin-8 |
| 06/11/2009 | WO2009073808A2 Compositions and methods to modulate cell membrane resealing |
| 06/11/2009 | WO2009073725A2 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| 06/11/2009 | WO2009073648A2 Compositions and methods for regulating entamoeba histolytica function |
| 06/11/2009 | WO2009073599A1 Process for reducing effects of graft versus host disease using ex vivo expanded cd4+cd25+ regulatory t cells |
| 06/11/2009 | WO2009073544A2 Methods for treating a disorder by regulating gprc6a |
| 06/11/2009 | WO2009073457A1 Methods and compositions for the rescue of a filtering bleb |
| 06/11/2009 | WO2009073330A2 Novel vaccines against multiple subtypes of influenza virus |
| 06/11/2009 | WO2009073192A2 Systems and methods for delivery of materials |
| 06/11/2009 | WO2009073146A2 Use of immunomodulatory compounds for the treatment of transverse myelitis, multiple sclerosis, and other disorders |
| 06/11/2009 | WO2009072831A2 Novel use of flj25416 gene |
| 06/11/2009 | WO2009072802A2 Composition for slimming |
| 06/11/2009 | WO2009072654A1 Radical therapeutic agent for keloid and hypertrophic scar |
| 06/11/2009 | WO2009072635A1 Method for amplifying hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | WO2009072594A1 Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink |
| 06/11/2009 | WO2009072119A2 Amphiphilic peptide matrices for treatment of osteoporosis |
| 06/11/2009 | WO2009071950A1 Methods for the detection of a threatened miscarriage |
| 06/11/2009 | WO2009071912A2 Material comprising nm23 linked to a substrate for use in treating neuron disorders |
| 06/11/2009 | WO2009071886A1 Fviii peptides and their use in tolerising haemophiliacs |
| 06/11/2009 | WO2009071850A2 Nanoparticles of therapeutic agents having low water solubility |
| 06/11/2009 | WO2009071732A1 Np1 activity regulating elements which can be used in the production of drugs for the treatment or prevention of human neurodegenerative diseases, resulting drugs and use thereof |
| 06/11/2009 | WO2009071680A2 Rna antagonist compounds for the modulation of mcl-1 |
| 06/11/2009 | WO2009071659A1 Trophic factor for the treatment of retinal degenerative diseases |
| 06/11/2009 | WO2009071601A1 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism |
| 06/11/2009 | WO2009071594A1 Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders |
| 06/11/2009 | WO2009071550A1 Protease variants for pharmaceutical use |
| 06/11/2009 | WO2009071097A1 Use of hypothermia inducing drugs |
| 06/11/2009 | WO2009071096A2 Combination of medical and physical cooling treatment of ischemic effects |
| 06/11/2009 | WO2009071034A1 Pharmaceutical cyclosporine composition and method for altering the solubility and stability thereof |
| 06/11/2009 | WO2009070957A1 Inhibitor of the interaction between blys and ngr and use thereof |
| 06/11/2009 | WO2009070818A1 Pharmaceutical preparation for treating benign prostatic hyperplasia |
| 06/11/2009 | WO2009055742A3 Delivery of active agents |
| 06/11/2009 | WO2009055740A3 Method of preventing adverse effects by glp-1 |
| 06/11/2009 | WO2009053467A3 The use of a non-glycanated polypeptide for treating a cancer |
| 06/11/2009 | WO2009052184A3 Compositions comprising optimized her1 and her3 multimers and methods of use thereof |
| 06/11/2009 | WO2009050738A3 An orally administerable solid pharmaceutical composition and a process thereof |
| 06/11/2009 | WO2009048658A9 Optimized dengue virus entry inhibitory peptide (dn81) |
| 06/11/2009 | WO2009033818A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033787A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033786A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033759A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033740A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033722A3 Use of a octreotide as a therapeutic agent |
| 06/11/2009 | WO2009033719A3 Use of a deslorelin and mastoparan as a therapeutic agent |
| 06/11/2009 | WO2009033717A3 Use of gonadorelin as a therapeutic agent |
| 06/11/2009 | WO2009027752A3 Process for producing hepcidin |
| 06/11/2009 | WO2009007112A4 Thrombomodulin for increasing reperfusion and preventing blood vessels obstruction |
| 06/11/2009 | WO2008140565A3 Use of tumor necrosis factor receptor 14 antagonists for treating psoriasis |
| 06/11/2009 | WO2008137901A8 Methods for treating and preventing gi syndrome and graft versus host disease |
| 06/11/2009 | WO2008042795A3 Histone acetyle transferase activators and histone deacetylase inhibitors in the treatment of alcoholism |
| 06/11/2009 | WO2008019147A3 Use of exendins, exendin agonists and glp-1 receptor agonists for altering the concentration of fibrinogen |
| 06/11/2009 | WO2006125171A3 Lumican proteoglycan in the diagnosis and treatment of atherosclerosis |
| 06/11/2009 | WO2006078404A3 Notch1 variants associated with cardiovascular disease |
| 06/11/2009 | WO2004069199A8 Marketing system for improving patient compliance and methods and devices relating to same |
| 06/11/2009 | WO2003050137A3 Toll-like receptor 4 mutations |
| 06/11/2009 | WO2003038038A3 16 human secreted proteins |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | WO2002089658A3 Microvascular free flaps for local or systemic delivery |
| 06/11/2009 | WO2002058484A3 Kolla 2-desiccated avian sternal cartilage powder |
| 06/11/2009 | WO2002048314A3 Antisense modulation of raidd expression |
| 06/11/2009 | WO2002047540A3 Methods for inhibiting fibrosis |
| 06/11/2009 | US20090151027 Mortierella ramanniana DAGAT proteins; using such sequences to alter triacylglycerol levels in plants and to treat diseases associated with altered DAGAT activity or expression |
| 06/11/2009 | US20090151013 Modified ES cells and ES cell-specific genes |
| 06/11/2009 | US20090149823 Application of Polymeric Materials to Screens To Facilitate Hemostasis And Wound Healing |
| 06/11/2009 | US20090149637 Human antibodies derived from immunized xenomice |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149630 Stabilized Alpha Helical Peptides and Uses Thereof |
| 06/11/2009 | US20090149629 Corticotropin releasing factor peptide for use in the treatment of nervous system and hypertensive disorders; (cyclo 31-34)[Ac-Pro4,D-Phe12,Nle18,21,Glu31,Lys34]-sucker urotensin |
| 06/11/2009 | US20090149412 Method for Inhibition of Phospholamban Activity for the Treatment of Cardiac Disease and Heart Failure |
| 06/11/2009 | US20090149410 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090149408 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; inflammatory, respiratory, proliferative, autoimmune, cardiovascular diseases |
| 06/11/2009 | US20090149407 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/11/2009 | US20090149406 Plasmid PXL3179 or NV1FGF |
| 06/11/2009 | US20090149394 Use of effectors of glutaminyl and glutamate cyclases |
| 06/11/2009 | US20090149393 Novel Proteins Within The Type E Botulinum Neurotoxin Complex |
| 06/11/2009 | US20090149392 Abuse-resistant amphetamine prodrugs |
| 06/11/2009 | US20090149391 Novel antimicrobial bolisin peptides |
| 06/11/2009 | US20090149390 Oxidant resistant apolipoprotein a-1 and mimetic peptides |
| 06/11/2009 | US20090149389 Kinase Inhibitors And Uses Thereof |
| 06/11/2009 | US20090149388 Dried blood factor composition comprising trehalose |
| 06/11/2009 | US20090149387 Use of GLP-1 Peptides |
| 06/11/2009 | US20090149386 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| 06/11/2009 | US20090149385 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| 06/11/2009 | US20090149384 Protection of Photoreceptors in Experimental Autoimmune Uveitis |